Literature DB >> 18191745

2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines.

Spencer B King, Sidney C Smith, John W Hirshfeld, Alice K Jacobs, Douglass A Morrison, David O Williams, Ted E Feldman, Morton J Kern, William W O'Neill, Hartzell V Schaff, Patrick L Whitlow, Cynthia D Adams, Jeffrey L Anderson, Christopher E Buller, Mark A Creager, Steven M Ettinger, Jonathan L Halperin, Sharon A Hunt, Harlan M Krumholz, Frederick G Kushner, Bruce W Lytle, Rick Nishimura, Richard L Page, Barbara Riegel, Lynn G Tarkington, Clyde W Yancy.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18191745     DOI： 10.1016/j.jacc.2007.10.002

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  96 in total

Review 1.  Molecular neurophysiology of taste in Drosophila.

Authors:  H Ishimoto; T Tanimura
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 2.  Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Authors:  H Benjamin Starnes; Ankit A Patel; George A Stouffer
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 3.  Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.

Authors:  Piera Capranzano; George Dangas
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

4.  Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents.

Authors:  Martino Pepe; Massimo Napodano; Giuseppe Tarantini; Chiara Fraccaro; Ada Cutolo; Diletta Peluso; Giambattista Isabella; Angelo Ramondo; Sabino Iliceto
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

5.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 6.  Contemporary issues on clopidogrel therapy.

Authors:  Giuseppe Patti; Germano Di Sciascio
Journal:  Intern Emerg Med       Date:  2009-01-08       Impact factor: 3.397

7.  Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease.

Authors:  Paul A Gurbel; Udaya S Tantry
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

8.  The CYP2C19*17 variant is not independently associated with clopidogrel response.

Authors:  J P Lewis; S H Stephens; R B Horenstein; J R O'Connell; K Ryan; C J Peer; W D Figg; S D Spencer; M A Pacanowski; B D Mitchell; A R Shuldiner
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

Review 9.  Medical therapy in acute coronary syndromes: which medicines and at what doses?

Authors:  Dmitriy Kireyev; Edward C Yun; Brian J Page; William E Boden
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

10.  [Health-economic modeling on the use of drug-eluting stents versus coronary artery bypass graft surgery in coronary heart disease].

Authors:  Vitali Gorenoi; Charalabos-Markos Dintsios; Matthias P Schönermark; Anja Hagen
Journal:  Herz       Date:  2009-05-16       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.